CDKN2B-AS1 and prostate carcinoma: Although ANRIL have been studied in a variety of physiological and pathological processes, such as glucose and fatty acid metabolism[24], neurofibromatosis type 1[40] and prostate cancer, the possible role and associated molecular mechanism of ANRIL in human gastric cancer remains to be clarified.